Update in the treatment of paediatric ulcerative colitis.

about

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.Infliximab for the treatment of pediatric ulcerative colitis.

P2860

Q38022238-C86BB817-83B7-42C0-9832-CB813AA5A5D1 Q38067127-48292FFF-B568-42EF-9B3F-EF30E9B9D61B

P2860

Update in the treatment of paediatric ulcerative colitis.

Item

http://www.wikidata.org/entity/Q36613876

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Update in the treatment of paediatric ulcerative colitis.

@ast

Update in the treatment of paediatric ulcerative colitis.

@en

type

Item

label

Update in the treatment of paediatric ulcerative colitis.

@ast

Update in the treatment of paediatric ulcerative colitis.

@en

prefLabel

Update in the treatment of paediatric ulcerative colitis.

@ast

Update in the treatment of paediatric ulcerative colitis.

@en

P1476

Update in the treatment of paediatric ulcerative colitis.

@en

P2093

James F Markowitz

http://www.w3.org/2001/XMLSchema#string

Melanie K Greifer

http://www.w3.org/2001/XMLSchema#string

P2860

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

Infliximab for induction and maintenance therapy for ulcerative colitis

Safety of infliximab treatment in pediatric patients with inflammatory bowel disease.

P304

1907-1918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.14.1907

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17020417

http://www.w3.org/2001/XMLSchema#string

Update in the treatment of paediatric ulcerative colitis.

about

P2860

P2860

Update in the treatment of paediatric ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698